DE3764290D1 - Verfahren zur herstellung von liposomen. - Google Patents

Verfahren zur herstellung von liposomen.

Info

Publication number
DE3764290D1
DE3764290D1 DE8787302866T DE3764290T DE3764290D1 DE 3764290 D1 DE3764290 D1 DE 3764290D1 DE 8787302866 T DE8787302866 T DE 8787302866T DE 3764290 T DE3764290 T DE 3764290T DE 3764290 D1 DE3764290 D1 DE 3764290D1
Authority
DE
Germany
Prior art keywords
organic solvent
producing liposome
liposomes
drug
liposome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787302866T
Other languages
English (en)
Inventor
Katsumi Iga
Naoru Hamaguchi
Yasuaki Ogawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE3764290D1 publication Critical patent/DE3764290D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
DE8787302866T 1986-04-02 1987-04-02 Verfahren zur herstellung von liposomen. Expired - Fee Related DE3764290D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7610286 1986-04-02

Publications (1)

Publication Number Publication Date
DE3764290D1 true DE3764290D1 (de) 1990-09-20

Family

ID=13595510

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787302866T Expired - Fee Related DE3764290D1 (de) 1986-04-02 1987-04-02 Verfahren zur herstellung von liposomen.

Country Status (8)

Country Link
US (1) US4877561A (de)
EP (1) EP0240346B1 (de)
JP (1) JPH0751496B2 (de)
AT (1) ATE55542T1 (de)
CA (1) CA1291425C (de)
DE (1) DE3764290D1 (de)
ES (1) ES2016842B3 (de)
GR (1) GR3001049T3 (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
US6406713B1 (en) * 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
JPS63290824A (ja) * 1987-05-22 1988-11-28 Sumitomo Chem Co Ltd ウイルス感染症治療剤
US5000886A (en) * 1987-05-26 1991-03-19 American Cyanamid Company Silicone-hardened pharmaceutical microcapsules and process of making the same
WO1989005151A1 (en) * 1987-12-04 1989-06-15 The Liposome Company, Inc. High integrity liposomes and method of preration and use
JPH01238537A (ja) * 1988-03-18 1989-09-22 Toyo Jozo Co Ltd 肝障害治療剤
EP0440742B1 (de) * 1988-10-27 1997-01-15 The Regents Of The University Of Minnesota Immunhilfsmittel aus Liposome enthaltend Lymphokin IL -2
US5352435A (en) * 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5656211A (en) * 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US6001335A (en) * 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5776429A (en) * 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5922304A (en) * 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US6146657A (en) * 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5305757A (en) * 1989-12-22 1994-04-26 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5820848A (en) * 1990-01-12 1998-10-13 The Liposome Company, Inc. Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
JP3131923B2 (ja) * 1990-01-12 2001-02-05 ザ リポソーム カンパニー，インコーポレイテッド 指状突起―融合リポソームおよびゲル
US5741513A (en) * 1990-02-08 1998-04-21 A. Natterman & Cie. Gmbh Alcoholic aqueous gel-like phospholipid composition, its use and topical preparations containing it
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
AR244546A1 (es) * 1990-10-30 1993-11-30 Gador Y Cia S A C I Lab Dr Procedimiento para la preparacion de liposomas de drogas insolubles en aceite en capsulas blandas de gelatina enterosolubles.
ES2074879T3 (es) * 1991-01-16 1995-09-16 Schering Corp Uso de interleuquina-10 en inmunoterapia adoptiva de cancer.
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5874062A (en) * 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
EP0624095B2 (de) * 1991-12-31 2005-07-20 Zymogenetics, Inc. Verfahren und zusammensetzungen zur verminderung von blutverlust
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
ES2041597B1 (es) * 1992-05-05 1994-06-01 Bazaco Joan Freixas Nuevo procedimiento para la preparacion de liposomas que encapsulan productos farmaceuticos y cosmeticos.
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US5736121A (en) * 1994-05-23 1998-04-07 Imarx Pharmaceutical Corp. Stabilized homogenous suspensions as computed tomography contrast agents
US6156337A (en) * 1994-07-08 2000-12-05 Opperbas Holding B.V. Method for high loading of vesicles with biopolymeric substances
DE4430592A1 (de) * 1994-08-20 1996-02-22 Max Delbrueck Centrum Liposomale Zubereitung, ihre Herstellung und ihre Verwendung
US6743779B1 (en) 1994-11-29 2004-06-01 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US5830430A (en) * 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US5997898A (en) * 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US6033645A (en) * 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6139819A (en) * 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6447800B2 (en) 1996-01-18 2002-09-10 The University Of British Columbia Method of loading preformed liposomes using ethanol
WO1997040679A1 (en) 1996-05-01 1997-11-06 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
CA2263568C (en) * 1996-09-11 2008-12-02 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a contrast agent and a renal vasodilator
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US20020128248A1 (en) * 1997-06-20 2002-09-12 Metaphore Pharmaceuticals, Inc SODm therapy for prevention and/or treatment of inflammatory disease
US6180620B1 (en) 1997-06-20 2001-01-30 G.D. Searle & Co. Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
US20050171198A1 (en) * 1997-06-20 2005-08-04 Metaphore Pharmaceuticals, Inc. SODm therapy for treatment, prevention, inhibition and reversal of inflammatory disease
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
NZ503513A (en) * 1997-09-18 2004-12-24 Skyepharma Inc Sustained-release liposomal anesthetic compositions
US20020039596A1 (en) 1997-11-14 2002-04-04 Hartoun Hartounian Production of multivesicular liposomes
US6123923A (en) * 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE69940735D1 (de) 1998-07-17 2009-05-28 Pacira Pharmaceuticals Inc Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
AU2002307343A1 (en) * 2001-04-17 2002-10-28 Genencor International, Inc. Method to bind enzyme to carrier using cationic copolymers and product produced thereby
IL158819A0 (en) * 2001-05-31 2004-05-12 Skyepharma Inc Encapsulation of nanosuspensions in liposomes and microspheres
US7125568B2 (en) * 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
TWI235066B (en) * 2001-10-03 2005-07-01 Celator Technologies Inc Liposome loading with metal ions
AU2002357396A1 (en) * 2001-12-31 2003-07-24 Elan Pharmaceuticals, Inc. Efficient liposomal encapsulation under mild conditions
WO2003059280A2 (en) * 2002-01-09 2003-07-24 Elan Pharmaceuticals, Inc. Efficient liposomal encapsulation
WO2003059279A2 (en) * 2002-01-09 2003-07-24 Elan Pharmaceuticals, Inc. Efficient liposomal encapsulation under mild conditions
DE10203923B4 (de) * 2002-01-31 2011-06-01 Klinipharm Gmbh Verfahren zur Erhöhung der Wasserlöslichkeit lipophiler Wirkstoffe, Herstellung von hochkonzentrierten wässrigen Zusammensetzungen dieser Wirkstoffe, derartige Produkte und ihre Verwendung
WO2006068890A2 (en) * 2004-12-14 2006-06-29 Transave, Inc. Lipid particles comprising bioactive agents, methods of preparing and uses thereof
WO2006071659A1 (en) * 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
KR100831627B1 (ko) 2006-05-11 2008-05-22 (주)아모레퍼시픽 수용성 생리활성 성분을 포집한 역상 다중층 베시클
CA2807357A1 (en) 2010-08-05 2012-02-09 Geetanjali Chandrashekhar Chimote Microparticle formulation for pulmonary drug delivery of anti-infective molecule for treatment of infectious diseases
CA2857604A1 (en) 2011-12-22 2013-06-27 Nuvo Research Gmbh Liposomal chlorite or chlorate compositions
EP2891495B1 (de) * 2012-08-28 2018-05-30 National University Corporation Hokkaido University Lipidmembranstruktur mit in einem nichtpolaren lösungsmittel dispergierbaren bakterienzellenbauelementen sowie verfahren zur herstellung davon
US9775789B2 (en) * 2012-12-06 2017-10-03 D & J Rosée Inc. Topical liposome compositions containing phenolic anti-inflammatory agents and their methods of preparation
EP3506882B1 (de) * 2016-08-30 2022-01-12 Bracco Suisse SA Herstellung von grössenkontrollierten mikropartikeln
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217344A (en) * 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
CH624011A5 (de) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US4394448A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4241046A (en) * 1978-11-30 1980-12-23 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
JPS55118415A (en) * 1979-02-28 1980-09-11 Pii Papahadojiyopo Dometoriosu Method of encapsulating biologically active substance in lipoid cell
JPS5782310A (en) * 1980-11-11 1982-05-22 Tanabe Seiyaku Co Ltd Production of liposome preparation
JPS5782311A (en) * 1980-11-11 1982-05-22 Tanabe Seiyaku Co Ltd Production of liposome preparation
DE3269611D1 (en) * 1981-07-02 1986-04-10 Hoffmann La Roche Process for preparing liposome solutions
WO1983003383A1 (en) * 1982-03-29 1983-10-13 Liposome Co Inc Stable plurilamellar vesicles
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
US4565696A (en) * 1983-08-03 1986-01-21 The Regents Of The University Of California Production of immunogens by antigen conjugation to liposomes
FR2561101B1 (fr) * 1984-03-13 1986-10-31 Paris Sud Universite Procede de preparation de liposomes et liposomes ainsi obtenus
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法

Also Published As

Publication number Publication date
EP0240346A3 (en) 1987-11-19
JPS6339810A (ja) 1988-02-20
EP0240346B1 (de) 1990-08-16
ATE55542T1 (de) 1990-09-15
US4877561A (en) 1989-10-31
JPH0751496B2 (ja) 1995-06-05
CA1291425C (en) 1991-10-29
EP0240346A2 (de) 1987-10-07
GR3001049T3 (en) 1992-01-20
ES2016842B3 (es) 1990-12-01

Similar Documents

Publication Publication Date Title
DE3764290D1 (de) Verfahren zur herstellung von liposomen.
AT375919B (de) Verfahren zur herstellung von neuen dehydrocyclischen iminosaeuren und deren estern
ATE18353T1 (de) Verfahren zur herstellung von liposomenloesungen.
ATE176873T1 (de) Verfahren zur herstellung von applikatoren zur transdermalen verabreichung von medikamenten
AT361121B (de) Verfahren zur herstellung von neuen 7beta-aryl- malonamido-7alpha-methoxy-3-thiadiazolylthio-1- -oxadethiacephalosporinen und deren estern und salzen mit basen
AT374477B (de) Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen
AT373887B (de) Verfahren zur herstellung von neuen n-heterocyclyl-4-piperidinaminen und deren saeureadditionssalzen
DE3680132D1 (de) Verfahren zur herstellung von optisch aktiver indolin-2-carbonsaeure.
ATA560779A (de) Verfahren zur herstellung von pharmazeutischen einheitsdosierungsformen
DE3686502T2 (de) Verfahren zur herstellung von optisch aktivem 2-halo-phenyl-ethanol.
ATA318081A (de) Verfahren zur herstellung von topischen verfahren zur herstellung von topischen pharmazeutischen zubereitungen pharmazeutischen zubereitungen
AT366662B (de) Verfahren zur herstellung von neuen 1-aryloxy-3- nitratoalkylamino-2-propanolen und deren saeureadditionssalzen
AT343631B (de) Verfahren zur herstellung von racemischem und optisch aktivem threo- und erythro-3-(3,4-dihydroxyphenyl)-serin
ATA785876A (de) Verfahren zur herstellung von neuen optisch aktiven 11-desoxy-16-aryl-omega-prostaglandinen
ATA630179A (de) Verfahren zur herstellung von neuen furylverbindungen und von deren salzen
AT372678B (de) Verfahren zur herstellung von neuen piperidinverbindungen und deren salzen
DE3683787D1 (de) Verfahren zur herstellung von optisch aktiven glykolderivaten.
ATA110179A (de) Verfahren zur herstellung von laevo-n-(1-aethyl-2 -pyrrolidino-methyl)-2'-methoxy-5'-sulfamoyl -bezamid
AT370099B (de) Verfahren zur herstellung von neuen tricyclischen verbindungen und deren salzen
ATA286579A (de) Verfahren zur herstellung von neuen pyrrolidinund piperidin-derivarten
AT377767B (de) Verfahren zur herstellung von neuen 4-aza-17subst.-5alpha-androstan-3-onen und deren pharmazeutisch verwendbaren salzen
AT347443B (de) Verfahren zur herstellung von neuen benzoylphenylindenen und -naphthalinen
ATA343279A (de) Verfahren zur herstellung von neuen bezoylphenoxy-alkansaeurederivaten und von deren salzen mit saeuren bzw. basen
AT372079B (de) Verfahren zur herstellung von neuen cyclododecanonoximaethern, ihren optisch aktiven isomeren, saeureadditionssalzen und quaternaeren ammoniumverbindungen
ATA798378A (de) Verfahren zur herstellung von aktivkohle

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee